| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 21, 2024 | LFWD Lifeward Ltd. | Jasinski Lawrence J62 | Chief Executive Officer | Sell | 1,620 | $4.91 | $7,954.20 | -1.5% | -27.0% | -76.5% | |
| May 21, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 20,000 | $0.90 | $18,016.00 | +0.1% | +8.4% | -31.5% | |
| May 21, 2024 | IART Integra Lifesciences Holdings Corp | Hill Barbara B | Director | Buy | 36,350 | $27.40 | $995,815.52 | New | -21.3% | -53.7% | |
| May 21, 2024 | SSII Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | Buy | 2,871 | $3.31 | $9,489.24 | - | - | - | |
| May 21, 2024 | INFU Infusystem Holdings, Inc | Chupa Addam | Executive VP And CIO | Buy | 1,000 | $6.67 | $6,670.00 | +4.2% | -3.9% | -8.7% | |
| May 20, 2024 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | CEO | Sell | 24,502 | $0.39 | $9,506.78 | -1.4% | -42.5% | -35.8% | |
| May 20, 2024 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 6,546 | $0.39 | $2,539.85 | -1.3% | -42.5% | -35.8% | |
| May 20, 2024 | PACB Pacific Biosciences Of California, Inc. | Farmer Michele68 | See Remarks | Sell | 5,275 | $2.03 | $10,708.25 | -2.4% | -16.7% | -46.9% | |
| May 20, 2024 | PEN Penumbra Inc | Elsesser Adam62 | CEO And President | Sell | 15,000 | $200.98 | $3,014,734.21 | -0.4% | -5.0% | +39.6% | |
| May 20, 2024 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 19,601 | $0.39 | $7,607.15 | -1.6% | -42.5% | -35.8% | |
| May 20, 2024 | PLSE Pulse Biosciences, Inc. | Barrett Burke Thomas | President And CEO | Buy | 10,000 | $8.56 | $85,600.00 | New | +132.6% | +99.0% | |
| May 20, 2024 | HAE Haemonetics Corp | Strong Stewart W67 | President, Global Hospital | Sell | 686 | $95.11 | $65,245.46 | -3.6% | -21.4% | -27.7% | |
| May 20, 2024 | INFU Infusystem Holdings, Inc | Funke Jerod | Evp-chief Hr Officer | Buy | 1,000 | $6.39 | $6,387.50 | New | -1.8% | -6.0% | |
| May 20, 2024 | INFU Infusystem Holdings, Inc | Steele Barry G | Executive VP And CFO | Buy | 3,000 | $6.47 | $19,398.30 | +4.5% | -1.8% | -6.0% | |
| May 20, 2024 | SRTS Sensus Healthcare, Inc. | Heinrich John62 | Director | Sell | 20,000 | $6.17 | $123,415.83 | -12.9% | +12.6% | -23.3% | |
| May 20, 2024 | INFU Infusystem Holdings, Inc | Gendron Paul Andrew | Director | Buy | 5,000 | $6.54 | $32,700.00 | +8.3% | -1.8% | -6.0% | |
| May 20, 2024 | HAE Haemonetics Corp | Llorens Josep59 | EVP, Global Manufacturing | Sell | 1,809 | $94.96 | $171,786.00 | -4.6% | -21.4% | -27.7% | |
| May 20, 2024 | HAE Haemonetics Corp | Basil Michelle L51 | EVP And General Counsel | Sell | 2,677 | $95.05 | $254,443.32 | -4.2% | -21.4% | -27.7% | |
| May 17, 2024 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 115 | $22.18 | $2,550.70 | - | +17.3% | +7.4% | |
| May 17, 2024 | RXST Rxsight, Inc. | Tammenoms Bakker Juliet | Director | Buy | 5,000 | $61.09 | $305,456.50 | +16.8% | -16.3% | -76.6% | |
| May 17, 2024 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 57 | $22.18 | $1,264.26 | - | +17.3% | +7.4% | |
| May 17, 2024 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 98 | $22.18 | $2,173.64 | - | +17.3% | +7.4% | |
| May 17, 2024 | TMCI Treace Medical Concepts, Inc. | Treace John T.60 | Chief Executive Officer | Buy | 100,000 | $5.56 | $556,170.00 | +1.6% | +19.6% | +34.4% | |
| May 17, 2024 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 85 | $22.18 | $1,885.30 | - | +17.3% | +7.4% | |
| May 17, 2024 | ZOMDF Zomedica Corp. | Powers Johnny D | Director | Buy | 100,000 | $0.17 | $17,450.00 | +2.3% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.